Log in to save to my catalogue

Oral Spherical Adsorptive Carbon for the Treatment of Intractable Anal Fistulas in Crohn's Disease:...

Oral Spherical Adsorptive Carbon for the Treatment of Intractable Anal Fistulas in Crohn's Disease:...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_69408595

Oral Spherical Adsorptive Carbon for the Treatment of Intractable Anal Fistulas in Crohn's Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

About this item

Full title

Oral Spherical Adsorptive Carbon for the Treatment of Intractable Anal Fistulas in Crohn's Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Publisher

Oxford: Blackwell Publishing

Journal title

The American journal of gastroenterology, 2008-07, Vol.103 (7), p.1721-?

Language

English

Formats

Publication information

Publisher

Oxford: Blackwell Publishing

More information

Scope and Contents

Contents

Anal fistulas are common in individuals with Crohn's disease (CD). We sought to evaluate the efficacy of oral spherical adsorptive carbon (AST-120) (Kremezin; Kureha Corporation, Tokyo, Japan) for the treatment of intractable anal fistulas in patients with CD.
In this multicenter, randomized, double-blind, placebo-controlled trial, patients with...

Alternative Titles

Full title

Oral Spherical Adsorptive Carbon for the Treatment of Intractable Anal Fistulas in Crohn's Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_69408595

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_69408595

Other Identifiers

ISSN

0002-9270

E-ISSN

1572-0241

DOI

10.1111/j.1572-0241.2008.01860.x

How to access this item